News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC
Photo from investor.agenusbio.com
Jun 28, 2024, 13:09

Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC

Vittorio Studiale, Medical Oncology Resident at University Hospital of Pisa, shared on X:

“Impressive pathological response rate (71%, pCR 35%) with neoadjuvant BOT/BAL in MSS colorectal cancer from the update of NEST-1 trial.”

Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC

Source: Vittorio Studiale/X

Agenus Balstilimab BOT/BAL BOT/BAL immunotherapy botensilimab cancer colorectal cancer ESMO ESMOGI24 European Society for Medical Oncology Garo Armen Jennifer Buell Mehraneh Jafari metastatic MSS colorectal cancer MSS CRC neoadjuvant BOT/BAL NEST-1 trial OncoDaily Oncology Pashtoon Kasi Steven O'Day Vittorio Studiale
Special Coverage
Blog
Dec 21, 2024, 11:52
Gevorg Tamamyan's first message as New POEM President
Blog
Dec 21, 2024, 11:30
Kyaw Thein: Tissue-Agnostic Drug Development in Cancer
Dialogues
Dec 21, 2024, 11:29
Beyond the Cancer Diagnosis: Dialogue with Marianne Arab, Hosted by Adrian Pogacian
Blog
Dec 21, 2024, 11:27
Aleix Prat: Carlos Fernandez de Larrea has been appointed as a Professor at the University of Barcelona
Blog
Dec 21, 2024, 11:25
Canadian Cancer Society - Natalie Wild's caregiver story
Blog
Dec 21, 2024, 11:24
Christy Brown: How many things can you dread more than 'your child has aggressive brain cancer?'
Blog
Dec 21, 2024, 11:18
Jose Fernando Moura: Pivotal SABCS24 summary hosted by Cancer Network
Blog
Dec 21, 2024, 11:18
Jérôme Salomon: President Macron, WHO Director-General and global health leaders inaugurate WHO Academy
Blog
Dec 21, 2024, 11:17
ChatGPT-Like AI Tool Promises to Speed Treatment Advances and Free Doctors’ Time by Matching Patients with Clinical Trials
Blog
Dec 21, 2024, 11:14
Mediamedic - Wenbin Zhou on Pyrotinib-based regimen in HER2-positive breast cancer
Blog
Dec 21, 2024, 11:12
Didier Verhoeven: Comparing survival in breast cancer in Belgian Breast Centres
Blog
Dec 21, 2024, 11:06
Every great journey has its finale - eCAN Joint Action